Advanced search
Publication Cover
Leukemia & Lymphoma Volume 41, 2001 - Issue 3-4
Submit an article Journal homepage
93
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Reduced-Dose CHOP Therapy for Elderly Patients with Non-Hodgkin's Lymphoma

Mayumi Mori Tokyo Metropolitan Geriatric Hospital, Itabashi-ku, TokyoCorrespondence[email protected]
,
Nozomi Niitsu Toho University, Oota-ku, Tokyo
,
Toshiyuki Takagi Chiba Cancer Center, Chiba
,
Junji Tomiyama Tokyo Metropolitan Bokuto Hospital, Sumida-ku, Tokyo
,
Takao Matsue Kameda General Hospital, Chiba
,
Yasunori Nakagawa Japan Red Cross Medical Center, Shibuya-ku, Tokyo
&
Rumiko Okamoto Tokyo Metropolitan Komagome Hospital, Bunkyo-ku, Tokyo, Japan
 show all
Pages 359-366 | Received 01 Aug 2000, Published online: 01 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Kensuke Kayamori, Katsuhiro Shono, Masahiro Onoda & Akira Yokota. (2019) Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma. Hematology 24:1, pages 52-59.
Read now
Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima & Yoshiharu Maeda. (2017) The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 58:3, pages 736-739.
Read now
Yu-Yu Tien, Brian K. Link, John M. Brooks, Kara Wright & Elizabeth Chrischilles. (2015) Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile. Leukemia & Lymphoma 56:1, pages 65-71.
Read now
Brian K. Link. (2012) Chemo-immunotherapy dosing in older patients with diffuse large B-cell lymphoma: is this how we should treat our parents?. Leukemia & Lymphoma 53:8, pages 1435-1436.
Read now

Articles from other publishers (12)

Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura, Kento Ishimine, Yudai Hayashi, Mano Mino, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Toshihiro Okuya & Tatsu Shimoyama. (2023) Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma. Annals of Hematology 102:6, pages 1485-1500.
Crossref
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Akihiko Kageyama, Yasushi Omuro & Tatsu Shimoyama. (2022) Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study. BMC Cancer 22:1.
Crossref
Yuka Morita, Yusuke Kanemasa, Yuki Sasaki, An Ohigashi, Taichi Tamura, Shohei Nakamura, Yu Yagi, Akihiko Kageyama, Yasushi Omuro & Tatsu Shimoyama. (2022) Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma. Medicine 101:10, pages e29028.
Crossref
Akihito Nagata, Yusuke Kanemasa, Yuki Sasaki, Shohei Nakamura, Toshihiro Okuya, Chikako Funasaka, Akihiko Kageyama, Tatsu Shimoyama & Yasushi Omuro. (2020) Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B‐cell lymphoma. Hematological Oncology 38:3, pages 309-317.
Crossref
Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Tsunekazu Hishima & Yasushi Omuro. (2018) Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma. Annals of Hematology 97:6, pages 999-1007.
Crossref
Yoshiko Naito, Hidenori Sasaki, Yasushi Takamatsu, Fumiaki Kiyomi & Kazuo Tamura. (2016) Retrospective Analysis of Treatment Outcomes and Geriatric Assessment in Elderly Malignant Lymphoma Patients. Journal of Clinical and Experimental Hematopathology 56:1, pages 43-49.
Crossref
Yasushi Takamatsu, Junji Suzumiya, Atae Utsunomiya, Koichi Maeda, Hitoshi Matsuoka, Hitoshi Suzushima, Junichi Tsukada, Keisuke Shibata & Kazuo Tamura. (2010) THP‐COP regimen for the treatment of peripheral T‐cell lymphoma and adult T‐cell leukemia/lymphoma: a multicenter phase II study. European Journal of Haematology 84:5, pages 391-397.
Crossref
Hisashi Tsurumi, Takeshi Hara, Naoe Goto, Nobuhiro Kanemura, Senji Kasahara, Michio Sawada, Ichiro Yasuda, Toshiki Yamada, Masahito Shimizu, Tsuyoshi Takami & Hisataka Moriwaki. (2007) A phase II study of a THP‐COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B‐cell lymphoma. Hematological Oncology 25:3, pages 107-114.
Crossref
Fumi Mizoroki, Yuko Hirose, Masayuki Sano, Haruhiko Fukuda, Kensei Tobinai, Masanobu Nakata, Masafumi Taniwaki, Fumio Kawano, Kimiharu Uozumi, Kenichi Sawada, Shiro Fukuhara, Kaori Nasu, Yoichiro Ohno, Hironobu Toki, Atsushi Togawa, Masahiro Kikuchi, Tomomitsu Hotta & Masanori Shimoyama. (2006) A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients: Japan Clinical Oncology Group Study JCOG9203. International Journal of Hematology 83:1, pages 55-62.
Crossref
Mayumi Mori, Kiyoshi Kitamura, Michihiko Masuda, Tomomitsu Hotta, Tamotsu Miyazaki, Akira B. Miura, Hideaki Mizoguchi, Akira Shibata, Hidehiko Saito, Tamotsu Matsuda, Toru Masaoka, Mine Harada, Yoshiyuki Niho & Fumimaro Takaku. (2005) Long-term Results of a Multicenter Randomized, Comparative Trial of Modified CHOP versus THP-COP versus THP-COPE Regimens in Elderly Patients with Non-Hodgkin's Lymphoma. International Journal of Hematology 81:3, pages 246-254.
Crossref
Toshiyuki TAKAGI. (2004) THE STANDARD TREATMENT MODALITY FOR MALIGNANT LYMPHOMA OF WALDEYER'S RING: A HISTORICAL OVERVIEW. Toukeibu Gan 30:3, pages 363-366.
Crossref
. (2002) Current Awareness in Hematological Oncology. Hematological Oncology 20:1, pages 43-50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.